ABBOTT LABORATORIES (ABT) Cash flow statement
Top 12 of 23 line items reported by ABT · 250+ in the full API →
ABBOTT LABORATORIES (ABT) · Cash Flow Statement
Consolidated Statements of Cash Flows
Quarterly · In millions USD, except per-share data · Latest filed Nov 4, 2026 · FY ends Dec 31
| Three Months Ended | ||||||
|---|---|---|---|---|---|---|
Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Trend | |
| Net Cash Flow from Operating Activities | $1,737 | $2,488 | $1,315 | $3,315 | $2,787 | |
| Net Income | 920 | 928 | 1,077 | 1,776 | 1,644 | |
| Net Cash Flow from Investing Activities | $(385) | $(673) | $(20,324) | $(913) | $(457) | |
| Capital Expenditures | -513 | -497 | -399 | -689 | -496 | |
| Other Investing Activities | (-1) | (-14) | (-34) | (-6) | (-4) | |
| Net Cash Flow from Financing Activities | $(2,405) | $(3,518) | $17,313 | $(1,397) | $(1,760) | |
| Common stock repurchased | -11 | -1,045 | -180 | -302 | -305 | |
| Dividends Paid | -1,094 | -1,102 | -1,098 | -1,030 | -1,031 | |
| Other financing activities | 0 | — | — | 0 | 0 | |
| Effect of Exchange Rate Changes | 1 | 4 | (23) | 6 | (10) | |
| Net Cash Flow | $(1,052) | $(1,699) | $(1,719) | $1,011 | $560 | |
| Free Cash Flow | 1,224 | 1,991 | 916 | 2,626 | 2,291 | |
Quarterly figures are derived from year-to-date filed amounts.
11 more line items available via the API
Depreciation & AmortizationStock-Based CompensationAccounts receivableInventoriesNet Debt Issued (Repaid)Total debt issuedShort-term debt issuedLong-term debt issuedTotal debt repaidShort-term debt repaidLong-term debt repaid